Gastroesophageal reflux: diagnosis and management

Area of Science:

• Gastroenterology
• Esophageal Diseases

Background:

• Chronic esophagitis poses significant pathologic risks.
• Persistent gastroesophageal reflux leads to repeated mucosal injury and healing cycles.
• This process can result in end-stage disease, including peptic stricture formation.

Purpose of the Study:

• To highlight the severe consequences of chronic esophagitis.
• To discuss current therapeutic strategies for managing reflux-induced esophageal damage.
• To identify future directions for esophageal function enhancement.

Main Methods:

• Literature review on the pathophysiology and treatment of chronic esophagitis.
• Analysis of the efficacy of current pharmacologic interventions.
• Discussion of the limitations of existing treatments and unmet needs.

Main Results:

• Chronic esophagitis, driven by reflux, has a high potential for severe complications.
• Peptic stricture is a significant end-stage complication of long-term esophageal damage.
• Acid production inhibitors represent the most effective current medical therapy.

Conclusions:

• The long-term effects of chronic esophagitis, particularly stricture development, are a major clinical concern.
• Current treatments primarily focus on acid suppression.
• Development of therapies to improve lower esophageal function is needed.